IFNG and cancer: Additionally, there were significant differences in the TME-related scores, including dysfunction score (P=0.0043), exclusion score (P=4.9e-06), MSI score (P=0.023), cancer-associated fibroblast (CAF) score (P=1.6e-1), TAM.M2 score (P=1.1e-08), and IFNG score (P=0.0053) between the high-risk and low-risk groups in GSE17538 (Figures 8D–I).